Opportunity Information: Apply for RFA CA 16 005
Apply for RFA CA 16 005
- The HHS-NIH11 in the education, health sector is offering a public funding opportunity titled "The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394, 93.395, 93.396, 93.398, 93.399.
- This funding opportunity was created on Dec 18, 2015 and posted on Dec 18, 2015.
- Applicants must submit their applications by Feb 19, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 30 candidate(s).
- Eligible applicants include: Public and State controlled institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00), listed under funding opportunity number RFA-CA-16-005, is a discretionary NIH/NCI grant opportunity designed to help strong doctoral students move smoothly from the last phase of their PhD training into a productive postdoctoral fellowship in cancer research. Its central goal is to encourage and retain graduate students who have already shown significant promise and a clear interest in becoming independent cancer researchers. Rather than treating the PhD and postdoc as disconnected stages, this award is structured to support the transition itself, with an emphasis on building a trajectory toward research independence.
The program is framed as a two-stage pathway award. In practical terms, it supports the final part of predoctoral training (the F99 phase) and then, once the recipient secures an appropriate postdoctoral position, provides continued support and structured career development during the postdoctoral period (the K00 phase). Across both phases, the intent is to position the awardee for a successful cancer-focused research career by combining research training with professional development activities that match long-term career goals. This can include activities that strengthen the skills needed to become an independent investigator, such as advanced technical training, responsible conduct of research, grant writing experience, publication planning, mentoring and networking, and other career development efforts aligned with the recipient's intended research path.
Administratively, the opportunity is offered by the U.S. Department of Health and Human Services through the National Institutes of Health, specifically NCI (agency listing shown as HHS-NIH11). It falls under the broad activity areas of education and health, and is associated with multiple CFDA numbers (93.394, 93.395, 93.396, 93.398, and 93.399), reflecting its placement within NIH/NCI funding catalogs. The funding instrument type is a grant. The posted and creation dates for this announcement were December 18, 2015, and the application closing date was February 19, 2016. The announcement anticipated making about 30 awards, and the record lists no explicit award ceiling.
Eligibility is broad on the institutional side, allowing applications through many kinds of organizations that can sponsor research training, including public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations other than small businesses, small businesses, and other entities as clarified in the full eligibility text of the announcement. In short, the program is built to identify and support high-potential doctoral trainees and to carry them through a key career inflection point, with the explicit purpose of strengthening the pipeline of future independent investigators in cancer research.
FAQs: NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) - RFA-CA-16-005
What is the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)?
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is a discretionary NIH/NCI grant opportunity designed to help strong doctoral students in cancer research transition smoothly from the final stage of their PhD training into a productive postdoctoral fellowship. The award is structured specifically to support that transition and to help set up a clear trajectory toward research independence.
What is the funding opportunity number for this program?
The funding opportunity number is RFA-CA-16-005.
What is the main purpose of the F99/K00 award?
The central purpose is to encourage and retain promising graduate students who have demonstrated significant potential and a clear interest in becoming independent cancer researchers. The program is built to strengthen the pipeline of future independent investigators in cancer research by supporting the transition from PhD training into postdoctoral training.
How is this award structured?
This is a two-stage pathway award. It supports the final part of predoctoral training (the F99 phase) and then provides continued support and structured career development during the postdoctoral period (the K00 phase), once the awardee secures an appropriate postdoctoral position.
What does the F99 phase support?
The F99 phase is intended to support the last phase of the recipient's predoctoral (PhD) training, helping them complete the final portion of their doctoral work as they prepare for a postdoctoral fellowship in cancer research.
What does the K00 phase support?
The K00 phase provides continued support and structured career development during the postdoctoral period after the recipient transitions into an appropriate postdoctoral position. The intent is to maintain momentum and help the awardee build toward research independence in cancer-focused research.
Is the program meant to connect the PhD and postdoc stages?
Yes. A defining feature of this opportunity is that it does not treat the PhD and postdoctoral training as disconnected stages. Instead, it is designed to support the transition itself as a key career inflection point.
What kinds of training or professional development activities does the award emphasize?
The program emphasizes a combination of research training and professional development aligned with long-term career goals. Examples specifically mentioned include advanced technical training, responsible conduct of research, grant writing experience, publication planning, mentoring and networking, and other career development efforts aligned with the recipient's intended research path.
What research area is this award focused on?
The award is focused on cancer research, with the explicit goal of developing future independent investigators in cancer-focused research careers.
Which agencies offer this opportunity?
The opportunity is offered by the U.S. Department of Health and Human Services (HHS) through the National Institutes of Health (NIH), specifically the National Cancer Institute (NCI). The agency listing is shown as HHS-NIH11.
What type of funding instrument is this?
The funding instrument type is a grant.
What are the activity areas associated with this opportunity?
The announcement is associated with the broad activity areas of education and health.
Which CFDA numbers are associated with this opportunity?
The opportunity is associated with multiple CFDA numbers: 93.394, 93.395, 93.396, 93.398, and 93.399.
When was this announcement posted and created?
The posted and creation dates listed for this announcement are December 18, 2015.
What was the application closing date listed in the announcement?
The application closing date listed is February 19, 2016.
How many awards were anticipated?
The announcement anticipated making about 30 awards.
Was an award ceiling specified?
No explicit award ceiling is listed in the record provided.
Who is this award intended to help?
It is intended to help strong doctoral students who have already shown significant promise and who have a clear interest in becoming independent cancer researchers, by supporting their move from late-stage PhD training into a postdoctoral fellowship.
What types of organizations are eligible to apply or sponsor applications?
Eligibility is broad on the institutional side. Organizations listed as eligible include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations other than small businesses, small businesses, and other entities as further clarified in the full eligibility text of the announcement.
Does the program require that a postdoctoral position be secured for the transition?
The structure described indicates that the K00 phase begins once the recipient secures an appropriate postdoctoral position, meaning the transition into the postdoctoral fellowship is a key step for moving into the postdoctoral (K00) support period.
What does "discretionary" mean in the context of this opportunity?
The opportunity is described as discretionary, meaning it is a specific NIH/NCI grant offering provided under the agency's discretionary funding authorities, as reflected in the announcement record.
Browse more opportunities from the same category: Education, Health
Next opportunity: ROSES 2015: Astrophysics Research and Analysis Program
Previous opportunity: ROSES 2015: K2 Guest Observer Cycle 4
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 16 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 16 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Behavioral and Integrative Treatment Development Program (R03) Apply for PA 16 074 Funding Number: PA 16 074 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $50,000 |
| Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21) Apply for PA 16 075 Funding Number: PA 16 075 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Behavioral and Integrative Treatment Development Program (R34) Apply for PA 16 073 Funding Number: PA 16 073 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $225,000 |
| Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01) Apply for PA 16 076 Funding Number: PA 16 076 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $500,000 |
| Behavioral Science Track Award for Rapid Transition (B/Start)(R03) Apply for PAR 16 071 Funding Number: PAR 16 071 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $75,000 |
| Behavioral and Integrative Treatment Development Program (R01) Apply for PA 16 072 Funding Number: PA 16 072 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20) Apply for PAR 16 084 Funding Number: PAR 16 084 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $275,000 |
| Supplements to Promote Clinical Research Studies on Pediatric Burkitt Lymphoma in Low- and Middle-Income Countries (Admin Supp) Apply for PA 16 086 Funding Number: PA 16 086 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $100,000 |
| Imaging and Biomarkers for Early Cancer Detection (U01) Apply for PAR 16 089 Funding Number: PAR 16 089 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44) Apply for RFA CA 16 008 Funding Number: RFA CA 16 008 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $1,000,000 |
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01) Apply for PAR 16 105 Funding Number: PAR 16 105 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $400,000 |
| Services Planning Research in the Appalachian Region to Address Adverse Health Consequences Associated with Increased Opioid Injection Drug Use (R03) Apply for RFA DA 16 015 Funding Number: RFA DA 16 015 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $100,000 |
| Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01) Apply for PAR 16 111 Funding Number: PAR 16 111 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $450,000 |
| Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects (R01) Apply for PAR 16 117 Funding Number: PAR 16 117 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21) Apply for PAR 16 123 Funding Number: PAR 16 123 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3) Apply for RFA DA 17 015 Funding Number: RFA DA 17 015 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $1,000,000 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01) Apply for PAR 16 122 Funding Number: PAR 16 122 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| The Application of Big Data Analytics to Drug Abuse Research (R01) Apply for PA 16 119 Funding Number: PA 16 119 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Emerging Questions in Cancer Systems Biology (U01) Apply for PAR 16 131 Funding Number: PAR 16 131 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25) Apply for PAR 16 138 Funding Number: PAR 16 138 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 16 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.